Caroline Kistorp
0000-0002-3019-6775
Rigshospitalet
8 papers found
Refreshing results…
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes
Serum Insulin-like Factor 3, Testosterone, and LH in Experimental and Therapeutic Testicular Suppression
Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus
Serum insulin-like factor 3 levels are reduced in former androgen users suggesting impaired Leydig cell capacity
Endogenous testosterone levels are associated with risk of type 2 diabetes in women without established comorbidity
Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
Missing publications? Search for publications with a matching author name.